Dubai Health Authority (DHA) and Mubadala Healthcare signed a Memorandum of Understanding (MoU) to collaborate pertaining to areas such as knowledge-sharing, partnership initiatives and improved access to care for patients in Dubai.
The initial focus will be on three of Mubadala Healthcare’s facilities, Wooridul Spine Centre, Tawam Molecular Imaging Centre and National Reference Laboratory. The MoU’s objective will be to facilitate patient and laboratory test referrals, knowledge exchange and the inclusion of these facilities in the Government of Dubai’s Enaya network.
Enaya, which is the Government of Dubai Employee Healthcare Benefits Scheme, provides a broad range of medical insurance coverage including treatment for almost all types of ailments. The Enaya network consists which of 39 Government-owned departments with more than 90,000 beneficiaries.
These beneficiaries, including Dubai Government employees and their families is expected to receive high quality services through direct access to Dubai Health Authority facilities and over a thousand service providers in the private sector within the Emirate of Dubai and beyond.
Wooridul Spine Centre is the first facility of its kind in the region, entirely dedicated to spine care with minimally invasive, highly advanced and world-renowned treatment principles. It is operated by spine care experts, Wooridul Spine Hospital of South Korea
Tawam Molecular Imaging Centre in Al Ain, a specialist medical imaging facility operates under Johns Hopkins Medicine International, the international arm of Baltimore-based Johns Hopkins Medicine. The centre features state-of-the-art PET.CT imaging systems that are essential in the early detection and tracking of cancer, cardiovascular and neurological diseases.
National Reference Laboratory established by Mubadala Healthcare provides high-quality medical diagnostic testing services. It has got two laboratory facilities, one in Dubai’s Biotechnology and Research Park (DuBiotech) and the main hub facility in Mussafah, Abu Dhabi.
National Reference Laboratory was created in partnership with and is operated by Laboratory Corporation of America (LabCorp), one of the world’s largest and most renowned clinical reference laboratory networks. Its goal is to help improve the breadth, coverage and efficiency of laboratory testing in the UAE.
“We are very excited to explore these areas of collaboration and build upon our solid relationship with Dubai Health Authority,” Suhail Mahmood Al Ansari, Executive Director, Mubadala Healthcare, said.
“At the same time, we are delighted to announce the National Reference Laboratory agreement as the first outcome of the MoU and look forward to expanding upon this in the coming months. It is through partnerships and knowledge-sharing initiatives like these that we hope to improve access to our world-class facilities and reduce the need for patients to seek treatment overseas,” he added.
Dr Mohammad Al Olama, CEO of Hospital Services Sector at DHA said: “At DHA, we are committed to providing specialized care for our patients and this MoU helps us achieve that. The collaboration will ensure our patients have access to world-class health facilities that are available in the UAE.”